Related Experiment Videos
The pathogenesis of atopic eczema
1Dermatopharmacology Unit, University of Southampton, Southampton General Hospital, Southampton SO16 6YD.
Hospital Medicine (London, England : 1998)
|December 12, 2002
Summary
Atopic eczema involves genetic immune system dysregulation, leading to T lymphocytes promoting immunoglobulin E (IgE) and allergic responses. Microbes like staphylococci and yeasts can worsen this inflammatory skin condition.
Area of Science:
- Immunology
- Dermatology
- Genetics
Background:
- Atopic eczema is a complex inflammatory skin disease.
- It has a known genetic component linked to immune system dysregulation.
- The role of specific immune responses and microbial factors is under investigation.
Purpose of the Study:
- To elucidate the immunological underpinnings of atopic eczema.
- To understand the genetic predisposition to immune dysregulation in eczema.
- To explore the contribution of microbial agents to the inflammatory process.
Main Methods:
- Genetic predisposition analysis.
- Immune cell differentiation studies (T lymphocytes, Th2 type).
- Immunoglobulin E (IgE) antibody level assessment.
- Microbial profiling (staphylococci, pityrosporum yeasts).
Main Results:
- Genetic factors predispose individuals to immune system dysregulation.
- T lymphocytes differentiate towards a Th2 phenotype.
- This differentiation promotes immunoglobulin E (IgE) production.
- Allergic responses to environmental allergens are facilitated.
- Microbes such as staphylococci and pityrosporum yeasts may exacerbate inflammation.
Conclusions:
- Atopic eczema pathogenesis involves a genetic predisposition to immune dysregulation.
- The Th2-skewed immune response and IgE production are key features.
- Microbial colonization can contribute significantly to the inflammatory cycle in atopic eczema.